Mitochondrial disease
Gene: ATP5A1
PMID: 34954817 reports three individuals with de novo monoallelic missense variants. One of these is the recurrent p.(Arg207His) variant while the other two variants are different substitutions. The three patients presented with a variable phenotypes: (1) a 14-year-old girl who presented during the first few months of life with developmental delay, failure-to-thrive, and lactic acidosis. She recovered and had no persistent neurologic phenotype; (2) a 17-year-old boy with psychomotor delay, intellectual disability, ataxia, spastic paraparesis, and dystonia; (3) a 12-year-old girl with psychomotor retardation, spastic tetraparesis, generalized dystonia, absent speech, swallowing problems, and increased blood lactate concentrations. Enzymatic investigations of muscle tissue from patient 1 showed a decrease in ATPase activity.Created: 7 Jan 2022, 5:58 a.m. | Last Modified: 7 Jan 2022, 5:58 a.m.
Panel Version: 0.685
PMID: 34483339; an identical de novo variant identified in 3 unrelated neonates presenting with feeding intolerance, failure to thrive, hyperammonemia and lactic acidemia. Although subclinical biochemical abnormalities persisted in each case, the major clinical symptoms appeared to remit by late infancy in all cases.Created: 3 Dec 2021, 3:42 a.m. | Last Modified: 3 Dec 2021, 3:42 a.m.
Panel Version: 0.674
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
feeding intolerance, failure to thrive, hyperammonemia, lactic acidemia
Publications
Comment when marking as ready: HGNC approved name: ATP5F1ACreated: 3 May 2020, 3:34 a.m. | Last Modified: 3 May 2020, 3:34 a.m.
Panel Version: 0.442
One family described with each of these mitochondrial conditions.Created: 7 Jan 2020, 8:10 a.m. | Last Modified: 7 Jan 2020, 8:10 a.m.
Panel Version: 0.36
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228
Publications
Phenotypes for gene: ATP5A1 were changed from Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228; Mitochondrial disorder, autosomal dominant to Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228; Mitochondrial disorder, autosomal dominant
Phenotypes for gene: ATP5A1 were changed from Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228 to Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228; Mitochondrial disorder, autosomal dominant
Publications for gene: ATP5A1 were set to 23599390
Mode of inheritance for gene: ATP5A1 was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Gene: atp5a1 has been classified as Amber List (Moderate Evidence).
Tag new gene name tag was added to gene: ATP5A1.
Gene: atp5a1 has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: ATP5A1 were changed from to Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228
Publications for gene: ATP5A1 were set to
Mode of inheritance for gene: ATP5A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
Gene: atp5a1 has been classified as Amber List (Moderate Evidence).
gene: ATP5A1 was added gene: ATP5A1 was added to Mitochondrial_AGHA_VCGS. Sources: Expert Review Green,Australian Genomics Health Alliance Mitochondrial Flagship,Victorian Clinical Genetics Services Mode of inheritance for gene: ATP5A1 was set to Unknown